Changing Dynamics in Pharma Distribution & Retailing

In the recent wake of GlaxoSmithKline’s decision to discontinue the practice of paying physicians to promote its pharmaceuticals and medical devices, pharma retailers are in a state of fix.

As argued succinctly by Phil Baumann in his influential article, the above decision only unearths more questions than answers. The most important of which is – Is the industry ready for such a change?